157 related articles for article (PubMed ID: 20488209)
1. The serotonin transporter gene polymorphism STin2 VNTR confers an increased risk of inconsistent response to triptans in migraine patients.
Terrazzino S; Viana M; Floriddia E; Monaco F; Mittino D; Sances G; Tassorelli C; Nappi G; Rinaldi M; Canonico PL; Genazzani AA
Eur J Pharmacol; 2010 Sep; 641(2-3):82-7. PubMed ID: 20488209
[TBL] [Abstract][Full Text] [Related]
2. Negative predictors of clinical response to triptans in patients with migraine.
Ishii M; Sakairi Y; Hara H; Imagawa A; Shimizu S; Takahashi J; Nagamine A; Naito Y; Masuda Y; Usami S; Kiuchi Y
Neurol Sci; 2012 Apr; 33(2):453-61. PubMed ID: 21822697
[TBL] [Abstract][Full Text] [Related]
3. G protein beta3 polymorphism and triptan response in cluster headache.
Schürks M; Kurth T; Stude P; Rimmbach C; de Jesus J; Jonjic M; Diener HC; Rosskopf D
Clin Pharmacol Ther; 2007 Oct; 82(4):396-401. PubMed ID: 17361120
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphisms related to efficacy and overuse of triptans in chronic migraine.
Gentile G; Borro M; Lala N; Missori S; Simmaco M; Martelletti P
J Headache Pain; 2010 Oct; 11(5):431-5. PubMed ID: 20652353
[TBL] [Abstract][Full Text] [Related]
5. STin2 VNTR polymorphism in the serotonin transporter gene and migraine: pooled and meta-analyses.
Schürks M; Rist PM; Kurth T
J Headache Pain; 2010 Aug; 11(4):317-26. PubMed ID: 20585826
[TBL] [Abstract][Full Text] [Related]
6. An opposite-direction modulation of the COMT Val158Met polymorphism on the clinical response to intrathecal morphine and triptans.
Cargnin S; Magnani F; Viana M; Tassorelli C; Mittino D; Cantello R; Sances G; Nappi G; Canonico PL; Genazzani AA; Raffaeli W; Terrazzino S
J Pain; 2013 Oct; 14(10):1097-106. PubMed ID: 23773341
[TBL] [Abstract][Full Text] [Related]
7. Association of 5-HTT gene polymorphisms with migraine: a systematic review and meta-analysis.
Liu H; Liu M; Wang Y; Wang XM; Qiu Y; Long JF; Zhang SP
J Neurol Sci; 2011 Jun; 305(1-2):57-66. PubMed ID: 21450309
[TBL] [Abstract][Full Text] [Related]
8. No direct association of serotonin transporter (STin2 VNTR) and receptor (HT 102T>C) gene variants in genetic susceptibility to migraine.
Joshi G; Pradhan S; Mittal B
Dis Markers; 2010; 29(5):223-9. PubMed ID: 21206007
[TBL] [Abstract][Full Text] [Related]
9. Identifying the factors underlying discontinuation of triptans.
Wells RE; Markowitz SY; Baron EP; Hentz JG; Kalidas K; Mathew PG; Halker R; Dodick DW; Schwedt TJ
Headache; 2014 Feb; 54(2):278-89. PubMed ID: 24001117
[TBL] [Abstract][Full Text] [Related]
10. Gene polymorphisms involved in triptans pharmacokinetics and pharmacodynamics in migraine therapy.
Gentile G; Borro M; Simmaco M; Missori S; Lala N; Martelletti P
Expert Opin Drug Metab Toxicol; 2011 Jan; 7(1):39-47. PubMed ID: 21142809
[TBL] [Abstract][Full Text] [Related]
11. SLC6A4 STin2 VNTR genetic polymorphism is associated with tobacco use disorder, but not with successful smoking cessation or smoking characteristics: a case control study.
Pizzo de Castro MR; Maes M; Guembarovski RL; Ariza CB; Reiche EM; Vargas HO; Vargas MM; de Melo LG; Dodd S; Berk M; Watanabe MA; Nunes SO
BMC Genet; 2014 Jun; 15():78. PubMed ID: 24968820
[TBL] [Abstract][Full Text] [Related]
12. Frequencies of genetic polymorphisms related to triptans metabolism in chronic migraine.
Gentile G; Missori S; Borro M; Sebastianelli A; Simmaco M; Martelletti P
J Headache Pain; 2010 Apr; 11(2):151-6. PubMed ID: 20213484
[TBL] [Abstract][Full Text] [Related]
13. Comparative efficacy of triptans for the abortive treatment of migraine: a multiple treatment comparison meta-analysis.
Thorlund K; Mills EJ; Wu P; Ramos E; Chatterjee A; Druyts E; Goadsby PJ
Cephalalgia; 2014 Apr; 34(4):258-67. PubMed ID: 24108308
[TBL] [Abstract][Full Text] [Related]
14. Association study between clinical response to rizatriptan and some candidate genes.
Asuni C; Cherchi A; Congiu D; Piccardi MP; Del Zompo M; Stochino ME
J Headache Pain; 2007 Jun; 8(3):185-9. PubMed ID: 17563839
[TBL] [Abstract][Full Text] [Related]
15. A global real-world assessment of the impact on health-related quality of life and work productivity of migraine in patients with insufficient versus good response to triptan medication.
Lombard L; Farrar M; Ye W; Kim Y; Cotton S; Buchanan AS; Jackson J; Joshi S
J Headache Pain; 2020 Apr; 21(1):41. PubMed ID: 32349662
[TBL] [Abstract][Full Text] [Related]
16. Association of polymorphic variants in serotonin re-uptake transporter gene with Crohn's disease: a retrospective case-control study.
Grubelic Ravić K; Paić F; Vucelić B; Brinar M; Čuković-Čavka S; Božina N; Krznarić Ž; Kalauz M; Bešić D; Nikuševa Martić T
Croat Med J; 2018 Oct; 59(5):232-243. PubMed ID: 30394015
[TBL] [Abstract][Full Text] [Related]
17. Altered allelic distributions of the serotonin transporter gene in migraine without aura and migraine with aura.
Ogilvie AD; Russell MB; Dhall P; Battersby S; Ulrich V; Smith CA; Goodwin GM; Harmar AJ; Olesen J
Cephalalgia; 1998 Jan; 18(1):23-6. PubMed ID: 9601620
[TBL] [Abstract][Full Text] [Related]
18. Significance of serotonin transporter gene polymorphism in migraine.
Yilmaz M; Erdal ME; Herken H; Cataloluk O; Barlas O ; Bayazit YA
J Neurol Sci; 2001 May; 186(1-2):27-30. PubMed ID: 11412868
[TBL] [Abstract][Full Text] [Related]
19. Using a Genetic Risk Score Approach to Predict Headache Response to Triptans in Migraine Without Aura.
Cargnin S; Viana M; Sances G; Cantello R; Tassorelli C; Terrazzino S
J Clin Pharmacol; 2019 Feb; 59(2):288-294. PubMed ID: 30256423
[TBL] [Abstract][Full Text] [Related]
20. Triptans in the Acute Treatment of Migraine: A Systematic Review and Network Meta-Analysis.
Cameron C; Kelly S; Hsieh SC; Murphy M; Chen L; Kotb A; Peterson J; Coyle D; Skidmore B; Gomes T; Clifford T; Wells G
Headache; 2015; 55 Suppl 4():221-35. PubMed ID: 26178694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
